scispace - formally typeset
P

Pierre Renard

Researcher at University of Caen Lower Normandy

Publications -  154
Citations -  4362

Pierre Renard is an academic researcher from University of Caen Lower Normandy. The author has contributed to research in topics: Melatonin & Receptor. The author has an hindex of 34, co-authored 154 publications receiving 4150 citations. Previous affiliations of Pierre Renard include Blaise Pascal University & Paul Sabatier University.

Papers
More filters
Journal ArticleDOI

Efficient selective synthesis of 2-substituted indoles from complex-base-promoted arynic cyclisations

TL;DR: 2-Substituted indoles have been efficiently obtained by selective arynic cyclisation of halogenated aryl imines of methyl ketones in the presence of the complex-base NaNH2–ButONa and by PhCH2SH–AlCl3 opening of tetrahydrothiopyranoindoles.
Journal ArticleDOI

Synthesis of tetracyclic dioxygenated isoquinolines and their cytotoxic activity

TL;DR: In this paper, an efficient synthesis of new dioxygenated isoquinolines was reported using tricyclic-nitril as a building block in a synthetic sequence of seven steps for the preparation of the tetracyclic isoquinoline and its derivatives.
Journal ArticleDOI

Novel Selective and Partial Agonists of 5‐HT3 Receptors. Part 1. Synthesis and Biological Evaluation of Piperazinopyrrolothienopyrazines.

TL;DR: A series of piperazinopyrrolo[1,2-a]thieno[3, 2-e]- and -[2,3-e]pyrazine derivatives were prepared and evaluated in order to determine the necessary requirements for high affinity on the 5-HT3 receptors and high selectivity versus other 5HT receptor subtypes.
Journal Article

Synthesis of 6-dialkylaminoalkylamino pyrano[2,3-c]acridones and benzo[b]pyrano[3,2-h]acridones: soluble acronycine analogues with increased cytotoxic activity.

TL;DR: In both series, the introduction of a dialkylaminoalkylamino side chain at position 6 resulted in a significant increase of the cytotoxic activity against L1210 cells when compared with the parent compounds bearing a methoxy group, accompanied with an increased potency to arrest cells in the G2 + M phases of the cell cycle.